Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
or

Neurocrine Bioscienc (NBIX)

Neurocrine Bioscienc (NBIX)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
106.73 +0.97 (+0.92%) 04/25/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 107.41 +0.68 (+0.64%) 16:03 ET
Quote Overview for Fri, Apr 25th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
104.42
Day High
107.54
Open 105.46
Previous Close 105.76 105.76
Volume 1,328,600 1,328,600
Avg Vol 1,831,130 1,831,130
Stochastic %K 92.01% 92.01%
Weighted Alpha -25.77 -25.77
5-Day Change +5.35 (+5.28%) +5.35 (+5.28%)
52-Week Range 84.23 - 157.98 84.23 - 157.98
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,463,420
  • Shares Outstanding, K 98,938
  • Annual Sales, $ 2,355 M
  • Annual Income, $ 341,300 K
  • EBIT $ 571 M
  • EBITDA $ 571 M
  • 60-Month Beta 0.33
  • Price/Sales 4.48
  • Price/Cash Flow 31.29
  • Price/Book 4.13

Options Overview Details

View History
  • Implied Volatility 59.20% ( +1.51%)
  • Historical Volatility 51.07%
  • IV Percentile 86%
  • IV Rank 50.94%
  • IV High 94.83% on 08/06/24
  • IV Low 22.21% on 05/16/24
  • Put/Call Vol Ratio 5.66
  • Today's Volume 2,124
  • Volume Avg (30-Day) 469
  • Put/Call OI Ratio 0.78
  • Today's Open Interest 16,029
  • Open Int (30-Day) 15,461

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 26 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 0.42
  • Number of Estimates 10
  • High Estimate 1.10
  • Low Estimate -0.30
  • Prior Year 0.42
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
84.23 +26.71%
on 04/09/25
Period Open: 116.18
116.23 -8.17%
on 03/26/25
-9.45 (-8.13%)
since 03/25/25
3-Month
84.23 +26.71%
on 04/09/25
Period Open: 148.73
154.61 -30.97%
on 01/30/25
-42.00 (-28.24%)
since 01/24/25
52-Week
84.23 +26.71%
on 04/09/25
Period Open: 137.76
157.98 -32.44%
on 08/01/24
-31.03 (-22.52%)
since 04/25/24

Most Recent Stories

More News
Implied Volatility Surging for Neurocrine Biosciences (NBIX) Stock Options

Investors in Neurocrine Biosciences, Inc. NBIX need to pay close attention to the stock based on moves in the options market lately. That is because the Dec 19, 2025 $70.00 Call had some of the highest...

NBIX : 106.73 (+0.92%)
Implied Volatility Surging for Neurocrine Biosciences (NBIX) Stock Options

Investors in Neurocrine Biosciences, Inc. NBIX need to pay close attention to the stock based on moves in the options market lately. That is because the Dec 19, 2025 $70.00 Call had some of the highest...

NBIX : 106.73 (+0.92%)
Neurocrine Biosciences: A Smart Biotech Bet With Blockbuster Potential

Explore the exciting world of Neurocrine Biosciences (NASDAQ: NBIX) with our expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends...

NVDA : 111.01 (+4.30%)
NBIX : 106.73 (+0.92%)
Why Neurocrine Biosciences Stock Sank Today

Despite better-than-expected profitability in the fourth quarter, which it reported late last week, Neurocrine Biosciences (NASDAQ: NBIX) hasn't been wowing analysts lately. On Monday, no less than three...

NBIX : 106.73 (+0.92%)
UBS : 30.02 (+0.70%)
Neurocrine Biosciences Reports Mixed Q4

Neurocrine Biosciences exceeded earnings expectations for Q4 2024, driven by robust sales from key product Ingrezza, while revenue slightly missed estimates.

NBIX : 106.73 (+0.92%)
TEVA : 14.87 (+1.02%)
Neurocrine: Q4 Earnings Snapshot

Neurocrine: Q4 Earnings Snapshot

NBIX : 106.73 (+0.92%)
Neurocrine: Q3 Earnings Snapshot

Neurocrine: Q3 Earnings Snapshot

NBIX : 106.73 (+0.92%)
Implied Volatility Surging for Neurocrine Biosciences (NBIX) Stock Options

Investors in Neurocrine Biosciences, Inc. NBIX need to pay close attention to the stock based on moves in the options market lately. That is because the Nov. 15, 2024 $80.00 Call had some of the highest...

NBIX : 106.73 (+0.92%)
"Rule Breaker Investing" Market Cap Game Show: Throwdowns & Long-Term Wins

Motley Fool analysts Matt Argersinger and Yasser El-Shimy face off.

MSFT : 391.85 (+1.17%)
SHOP : 97.12 (+2.10%)
LOW : 220.91 (-0.51%)
TDG : 1,378.13 (+0.74%)
NBIX : 106.73 (+0.92%)
AMD : 96.64 (+2.30%)
RKLB : 22.38 (+2.29%)
SONO : 9.22 (+0.77%)
HEI : 246.01 (-0.49%)
SYNA : 56.79 (+1.18%)
KFRC : 43.91 (-0.30%)
3 Top Growth Stocks to Buy at a Discount This Month

According to analysts, here are three top-notch mid-cap growth stocks to snag at a discount now.

SON : 46.19 (-0.45%)
$SPX : 5,525.21 (+0.74%)
NBIX : 106.73 (+0.92%)
$IDX : 2,831.67 (-0.42%)
FLR : 35.56 (-0.11%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Neurocrine Biosciences is a neuroscience-based company focused on the discovery and development of novel therapeutics for neuropsychiatric, neuroinflammatory and neurodegenerative diseases and disorders. The company's neuroscience, endocrine and immunology disciplines provide a unique biological understanding...

See More

Key Turning Points

3rd Resistance Point 111.16
2nd Resistance Point 109.35
1st Resistance Point 108.04
Last Price 106.73
1st Support Level 104.92
2nd Support Level 103.11
3rd Support Level 101.80

See More

52-Week High 157.98
Fibonacci 61.8% 129.81
Fibonacci 50% 121.10
Fibonacci 38.2% 112.40
Last Price 106.73
52-Week Low 84.23

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective